Volume | 8,235 |
|
|||||
News | - | ||||||
Day High | 10.60 | Low High |
|||||
Day Low | 10.26 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Treace Medical Concepts Inc | TMCI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
10.35 | 10.26 | 10.60 | 10.30 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
101 | 8,235 | $ 10.37 | $ 85,405 | - | 5.27 - 27.70 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:47:38 | 4 | $ 10.50 | USD |
Treace Medical Concepts Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
636.08M | 61.76M | - | 187.12M | -49.53M | -0.80 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Treace Medical Concepts News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TMCI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 11.22 | 11.51 | 10.23 | 10.76 | 314,828 | -0.68 | -6.06% |
1 Month | 13.04 | 13.24 | 10.23 | 11.69 | 308,697 | -2.50 | -19.17% |
3 Months | 13.91 | 15.98 | 10.23 | 13.15 | 399,961 | -3.37 | -24.23% |
6 Months | 9.46 | 15.98 | 5.27 | 10.58 | 704,252 | 1.08 | 11.42% |
1 Year | 25.90 | 27.70 | 5.27 | 13.63 | 598,081 | -15.36 | -59.31% |
3 Years | 26.20 | 37.17 | 5.27 | 18.08 | 385,162 | -15.66 | -59.77% |
5 Years | 24.50 | 37.17 | 5.27 | 18.17 | 389,252 | -13.96 | -56.98% |
Treace Medical Concepts Description
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals. |